TRIGONE WAS FOUNDED WITH THE GOAL OF ADDRESSING UNMET MEDICAL NEEDS RELATED TO BLADDER DISEASE
To achieve our goal, our experienced team leverages their deep understanding of bladder physiology to develop drug delivery systems for effective relief of bladder disorders.
Trigone proprietary intravesical treatments are designed to address complex bladder disease where other approaches aren’t providing the desired results.
Our approach enables the generation of highly targeted treatments which aims to achieve optimal durable therapeutic effect in the bladder, restoring the patents’ quality of life.
Our clinical pipeline features effective and safe therapies exerting prolonged drug exposure to the target organ, primarily required for good clinical outcomes of bladder cancer or bladder pain syndrome.
Fill out the form bellow